+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Central Nervous System Malignancies, An Issue of Hematology/Oncology Clinics of North America. The Clinics: Internal Medicine Volume 36-1

  • Book

  • November 2021
  • Region: North America
  • Elsevier Health Science
  • ID: 5514683
In this issue of�Hematology/Oncology�Clinics,�guest�editor�David A. Reardon?�brings�his�considerable expertise to the topic of�Central Nervous System Malignancies. Top experts in the field cover key topics such�as�CNS Metastases,�Leptomeningeal Disease,�Neurofibromatoses,�Imaging Advances for CNS Tumors, and more.
  • Contains�16�relevant, practice-oriented topics�including�CNS Tumor Classification: An Update on the Integration of Tumor Genetics;�Etiology and Epidemiology of CNS Tumors;�The Evolving Role of Neurosurgical Intervention for CNS Tumor�;�Update on Radiation Therapy for CNS Tumors; and more.�

  • Provides in-depth�clinical reviews on�CNS Malignancies,�offering�actionable insights for clinical practice.�

  • Presents the�latest information on this timely, focused topic�under the leadership of experienced editors in the field.�Authors synthesize and distill the latest research and practice guidelines to create�clinically significant,�topic-based reviews.�

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

Central Nervous System Tumor Classification: An Update on the Integration of Tumor GeneticsThe Epidemiology of Central Nervous System TumorsImaging Advances for Central Nervous System TumorsThe Evolving Role of Neurosurgical Intervention for Central Nervous System TumorsUpdate on Radiation Therapy for Central Nervous System TumorsIsocitrate Dehydrogenase Mutant Grade II and III Glial NeoplasmsIsocitrate Dehydrogenase Wild-type Glial Tumors, Including GlioblastomaBiology and Treatment of Meningiomas: A ReappraisalPrimary Central Nervous System LymphomasCentral Nervous System MetastasesLeptomeningeal DiseaseCentral Nervous System Complications Among Oncology PatientsIs There a Role for Immunotherapy in Central Nervous System Cancers?NeurofibromatosesNeurocognition and Health-Related Quality of Life Among Patients with Brain TumorsDisparities and Inequities Among Patients with Central Nervous System Tumor

Authors

David A. Reardon Clinical Director
Center for Neuro-Oncology
Dana-Farber Cancer Institute
Boston, MA.